MedTrace Logo

Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors

NCT03427632 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2018-02-09

No results posted yet for this study

Summary

Percutaneous vertebroplasty is a new technique to strengthen bone and reduce pain for patients with vertebral tumors

Conditions

  • Bone Tumor

Interventions

DRUG

Bone Cements

patents in PVP group will get injected with bone cement inside the collapsed malignant vertebra

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nisreen Abbas, MD · Assiut University

Eligibility

Min Age
1 Year
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-03-01
Completion
2019-03-01
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427632 on ClinicalTrials.gov